Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Debt Ratio: 2015-2020

Historic Debt Ratio for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to 0.02.

  • Outlook Therapeutics' Debt Ratio fell 91.15% to 0.02 in Q2 2020 from the same period last year, while for Jun 2020 it was 0.02, marking a year-over-year decrease of 91.15%. This contributed to the annual value of 0.39 for FY2019, which is 5220.59% up from last year.
  • Outlook Therapeutics' Debt Ratio amounted to 0.02 in Q2 2020, which was up 823.01% from 0.00 recorded in Q1 2020.
  • Outlook Therapeutics' Debt Ratio's 5-year high stood at 0.68 during Q2 2017, with a 5-year trough of 0.00 in Q1 2020.
  • Over the past 3 years, Outlook Therapeutics' median Debt Ratio value was 0.29 (recorded in 2018), while the average stood at 0.24.
  • Its Debt Ratio has fluctuated over the past 5 years, first spiked by 5,220.59% in 2019, then plummeted by 99.56% in 2020.
  • Quarterly analysis of 5 years shows Outlook Therapeutics' Debt Ratio stood at 0.25 in 2016, then skyrocketed by 52.47% to 0.38 in 2017, then grew by 27.90% to 0.49 in 2018, then tumbled by 99.25% to 0.00 in 2019, then tumbled by 91.15% to 0.02 in 2020.
  • Its Debt Ratio stands at 0.02 for Q2 2020, versus 0.00 for Q1 2020 and 0.00 for Q4 2019.